Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.
All content for Pharmacy Insights Podcast is the property of Optum Rx and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.
The use of artificial intelligence has exploded into the public consciousness in recent years. While people are becoming more accustomed to the presence of AI in their personal lives, what does it mean for pharmacy care services?
On the latest episode of the Pharmacy Insights Podcast, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Santiago Abraham, Chief Information Officer at Optum Rx and Sid Sahni, Senior Vice President of Strategy and Innovation at Optum Rx to discuss how Optum Rx is approaching the use of AI and what that means for sponsors and users of pharmacy benefits.
Pharmacy Insights Podcast
Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.
